 2
摘要 
由於現代醫學的進步，人類壽命普遍增長，DNA的解析以及組織的移植與
取代已是十分普遍的技術，故生醫工程在近代科技的發展已不容小覷。尤其近年
來奈米技術蓬勃發展，藉由降低材料尺寸大小，對於提昇或改進材料特性與功能
具有相當之功效。氫氧基磷灰石與生物體骨組織有相近的化學性質及結晶結構，
具有優良的生物相容性與骨導引性。奈米級的氫氧基磷灰石已被期盼為21世紀生
醫材料的明星，除可作為硬組織取代材料外，尚可用於蛋白質的純化以及藥物載
體，為合成奈米級的氫氧基磷灰石，諸如溶液凝膠合成法、水解合成法或微乳膠
法…等各種方法均被廣泛使用。本計畫為「近球形奈米級氫氧基磷灰石之合成」，
分別從陰陽離子型複合界面活性劑微胞控制低溫煅燒處理性質研究及燒結與應
用評估著手，以研究不同形狀及尺寸之奈米級氫氧基磷灰石之表面性質差異，及
其相關應用。藉由陰陽離子型界面分散劑於溶液中形成微胞，探討兩界面分散劑
於不同劑量比下形成奈米級氫氧基磷灰石之特性。探討氫氧基磷灰石之熱穩定性
與表面型態改變，並與商業粉末相互比較，在經由生物測試以評估其應用性。 
 
 
 
 
 
 
 
 
 
 
 4
50 nm。Jarcho等人[10]以硝酸鈣與磷酸氫銨為原料合成HA時發現，溶液最先析
出的是非晶質磷酸鹽（Amorphous calcium phosphate, ACP），ACP經以適當的
溫度、時間及pH值成熟後，轉變成缺陷型氫氧基磷灰石（DHA, 
Ca9(HPO4)(PO4)5(OH) , Ca/P莫耳比為1.5）或HA（Ca10(PO4)6(OH)2 , Ca/P莫耳比
為1.67）[11]。DHA又可進一步轉變成Whitlockite（WH, Ca10HPO4(PO4)6 , Ca/P
莫耳比為1.43）。WH與HA的相對含量則視析出粉末之Ca/P莫耳比而決定，Ca/P
莫耳比越接近1.67則HA含量越多，反之，WH越多。HA在醫學用途上幾乎都和含水
的環境接觸，其在室溫下之水溶液中的穩定性與溶液的pH值有關，Driessens[7]
認為，當pH值大於4.2時，HA為一穩定相，但當pH值小於4.2時，則以次磷酸鈣
（CaHPO4‧2H2O）為穩定相。 
根據研究顯示，當材料的特徵尺寸降低至奈米層級時，將表現出不同於塊
材的特性，尤其趨近量子效應尺寸大小時，材料展現不同於傳統材料的新奇特性
及優異的性能，在生醫技術突飛猛進的今日，奈米技術之貢獻意義將更為重大
[12]。奈米結構材料的定義是粉體顆粒大小介於1-100 nm之間的顆粒或結構材
料，其特性為：(一)具有與一般固體晶相或非晶質結構不同之原子結構；(二)
具有與其成份相同但為傳統晶粒或非晶質材料不同之性質，如光學、磁性、熱傳、
擴散以及機械等性質；(三)可使原本無法混合的金屬或聚合物而形成合金。由於
其粒徑極為細微，因此會有極大的比表面積，使表面能量佔全能量的比例大幅增
高。奈米微粒材料正因其極細微的粒徑，具有較大的表面能量和易變化的電子能
階，使奈米晶粒有著比塊材更優異的物理化學性質，如單磁區、低燒結溫度、觸
媒活性、低熱膨脹性、光感性等。因此，奈米晶粒材料具有機械材料強度高，延
性佳，耐磨耗以及耐腐蝕行為，高熱傳導性，高擴散性等性質。同時，奈米級材
料由於其細微的結構而具有溶解度高及原子擴散速率快，對於觸媒反應等的應用
有極大的幫助。運用奈米微粒、量子點等奈米材料或元件，經生物分子修飾後，
可將這些新型的極微小裝置或儀器用於醫療檢測、疾病治療、藥物釋放、生物移
植、仿生物感測、基因治療、免疫診斷和核磁共振顯影劑等應用。 
 6
第二章 實驗方法與步驟 
1 實驗程序 
    本研究採用水解法製備氫氧基磷灰石粉末，其製程分為兩部分，首先針對
溫度，時間與水解環境之改變進行原始粉末性質影響之測定，並探討陽離子型介
面分散劑對於製備氫氧基磷灰石粉末之影響；另一製程則是探討添加碳酸鈣改變
鈣磷比(Ca/P ratio)對於粉末基本性質之影響，並作為燒結性質量測用的原始粉
末。 
 
1-1 對照組之基本分析 
    先將去離子水加入氫氧化鈉後，再加入足夠的去離子水，調配成不同濃度
的NaOH水溶液(0.1 M，0.5 M，1 M，2.5 M，5 M，10 M)，再取100 ml NaOH水溶
液置於250 ml的燒杯中，加入攪拌子，分別在水浴槽中攪拌加熱至不同的反應溫
度(30，45，60與75oC)，而後秤量0.86 g二水磷酸氫鈣(0.05 M DCPD)粉末，在
水溶液加熱到所需溫度後持溫10 min再加入DCPD粉末持續攪拌，而後用保鮮膜封
住杯口以保持水量及實驗環境，再以鋁箔紙蓋住水浴槽減少輻射熱損失，於不同
水解處理時間(1 h，2 h，4 h，8 h，24 h)後取出燒杯，並置入冰水共存之0oC
水中終止水解反應。待水溶液降溫，以離心機將粉末分離出 (DCPD以及HA在水中
僅微溶，且本反應於高鹼環境(pH>10)下，為一固體-固體之迅速轉變反應，因此
可忽略溶解部份之影響，再將粉末以去離子水重複清洗及離心各五次，以去除表
面殘留之NaOH，於大氣下以烘箱烘乾(60oC，24 h)，而後研磨過篩(300 mesh)待
測。 
    溶劑的改變則以不同濃度的酒精-水溶液(0A-100W，10A-90W，30A-70W，
50A-50W，70A-30W，90A-10W，)調配NaOH(aq)，以10A-90W為例配製1000ml的溶液，
取100 ml之酒精(A)與900 ml的水(W)混合，由於水與酒精會產生氫鍵，可以完全
互溶，但體積則略減，因此不會得到1000ml的溶液，再以此溶液依照先前調配方
法配製NaOH水溶液，而後進行HA粉末之水解合成。 
 
1-2 陽離子型介面分散劑之添加 
    取100 ml 2.5 M NaOH水溶液與攪拌子置於250 ml燒杯中，逾75oC持溫10 min
 8
第三章 結果與討論 
3-1 溶劑改變 
溶劑為佔大多部份的基質，對實驗結果當有一定程度的影響，最常使用的溶
劑是水，而酒精則是最常被使用的有機溶劑，而此兩者有相當良好的互溶。因此
將酒精與水做不同程度的混合，藉以探討溶劑對本研究之結果所造成的影響。 
圖1所示者為在不同酒精(A)-水(W)濃度比例NaOH水溶液中(0A-100W ~ 
90A-10W)，於75oC經水解合成1 h後所得之HA粉末的XRD繞射圖。由於酒精之沸點
為78oC，因此無法使用100%純酒精進行測試，與先前製程所獲得之HA，同樣可獲
得純相HA，但在(002)與最強峰值群則有非常明顯的變化，(002)的繞射峰強度隨
著酒精濃度的增加而上升，在50A-50W時為一達到最高值之狹長的峰型，但繞射
角並無明顯變化，造成此一差別結果之原因應來自於晶體的規則排列及成長。此
外，比較最強峰值群的結果發現，(300)繞射峰的分離狀況在50A-50W時最為明
顯，且強度亦較在其他比例所形成者為高，仍存有寬化現象。在酒精濃度高於50%
後，70A-30W與90A-10W的XRD結果顯示(002)繞射峰強度大幅降低，並由JCPD card
可知HA之(002)標準強度為最強峰值(I211)的40%，顯示在50-70%酒精溶液環境中
所合成之HA歷經一個結構上的變化，使(002)的異向性結晶現象完全消失，此變
化將以zeta電位分析後討論。 
圖2是以(a)0A-100W，(b)50A-50W與(c)90A-10W 3個濃度比例所合成之HA粉
末的SEM影像，當無酒精時(即0A-100W)(圖2(a))，所有析出的HA有均勻的形狀與
大小。但添加50%酒精後(即50A-50W)(圖2(b))，可在原先析出物的周圍另外發現
許多微小的析出物，而在90%酒精添加後(即90A-10W)(圖2 (c))，這些微小析出
物反而成為主相，由XRD的結果可知不論其形狀與大小，所有析出物皆是HA。 
HA在醇類水溶液中的穩定性取決於路易士酸鹼反應(Lewis acid-base 
interactions)，即電洞–電子反應、電雙層排斥、以及凡得瓦耳力三者之間的
作用結果，酒精(乙醇)同時具有微酸與微鹼的性質，較之水為酸性較弱者，亦即
水可比酒精接受更多的HA的表面電子，因此HA在酒精環境中較不穩定，造成HA
的水解合成反應劇烈，析出物顆粒更小。 
進行zeta potential量測以驗證在不同酒精環境中水解合成之原料DCPD與
生成物HA表面電位的改變，如圖3所示，DCPD在純水環境中之表面電位為-26 mV，
 10
 
    
Fig. 2 The SEM images of synthesized HA powder from DCPD in 2.5 M NaOH(aq) at 
75oC for 1 h with various alcohol concentrations of： (a)0A-100W, 
(b)50A-50W, and (c)90A-10W. 
 
 
 
0 20 40 60 80 100
-30
-20
-10
0
10
20
30
 
 
Su
rf
ac
e 
po
te
nt
ia
l (
m
V)
Alcohol content (%)
 HA
 DCPD
 
Fig. 3 The surface potential of HA and DCPD in solutions with various alcohol 
concentrations. 
 
500nm 500nm 500nm 
(a) (c)(b)
 12
磷灰石結構，但較容易因溶入取代性雜質(substitutional impurity)而造成缺
陷，因離子半徑之差異而造成晶格常數的改變。本實驗中以NaOH為水解物質，Na+
離子容易在水解製程中取代結構中的Ca2+離子，兩離子的半徑差約為15%，因此本
研究所得之HA具有較小的a值以及加長的c值。 
    HA在不同之pH環境下皆呈負表面電位(zeta potential)，而CTAB的行為則與
環境電荷表現及化學性質相關。於水溶液中，CTAB呈現完全解離狀態，而成正方
晶系結構(tetrahedral structure)的陽離子，溶於水溶液中的陰性磷酸根離子
亦呈現正方晶系結構。因此電荷以及結構的互補賦予CTAB控制結晶過程的能力，
而分子的電荷行為進而造成產物特性的改變。 
    圖5中的寬化繞射峰，可由雪若方程式(Scherrer＇s formula)計算出晶粒大
小： 
x = 0.9λ / βs cosθ                        (2) 
其中x為合成之HA粉末的晶粒大小，λ=1.5418 Å為銅靶的Kα波長，β為繞射峰
的半高寬(full width at half maximum intensity, FWHM)，θ則是布拉格角度。
從測試各晶格面的繞射峰寬度，可決定在特定軸向的粒徑，本研究以分離度最高
的(002)面進行計算，亦即可求得c軸向之粒徑。 
    圖7所示為不同CTAB添加濃度所合成之HA粉末晶粒大小，未添加CTAB時所合
成的粉末粒徑約為22.0 nm，但HA之晶粒大小隨添加之濃度的增加而遞減，在濃
度1 × 10-3 M時達到最小值17.3 nm。 
    由於電荷以及立體化學的互補性，在無機/有機介面上曾發現所謂分子附著
力(molecule recognition)的因素[16,17]，一般而言，添加介面活性劑的作用
在於結合特定晶格面與特定離子，若此特定離子以穩定之比例結合而進入晶格內
部，則可進一步控制晶體的形狀與大小。本研究所得之微細HA晶體的形成亦因微
乳膠法(microemulsion method)形成了奈米級的不連續性微反應器(微胞)，阻止
了晶粒成長。過高的濃度造成CTAB多以微胞型態出現，對於與HA表面結合控制晶
體成長的能力因而下降，造成在CMC時有最小之晶粒。 
    圖8所示者為未添加以及添加3×10-3 M之CTAB後所得之HA粉末的TEM照片以及
電子繞射圖(electron diffraction, ED)，圖8(a)為未添加前析出物的明視野
像，呈寬50 nm及長100 nm的短棍狀，而圖8(a)為添加後的明視野(bright field, 
BF)圖像，析出物尺寸縮小為寬20 nm及長50 nm，(c)與(d)分別為(b)中圈選區的
 14
 
 
9.30
9.35
9.40
9.45
6.88
6.90
6.92
6.94
6.96
1x10-4 0.011x10-33x10-4 3x10-3
 
La
tti
ce
 p
ar
am
et
er
 a
 (n
m
)
Concentration of CTAB (M)
 L
at
tic
e 
pa
ra
m
et
er
 c
 (n
m
)
 
Fig. 6 Lattice parameters of the synthesized HA with various CTAB concentrations 
for. (□, a value with CTAB; ○, a value of JCPDs; ▲, c value with CTAB; ▼, 
c value of JCPDs) 
 
 
17
18
19
20
21
22
23
0.013x10-31x10-33x10-41x10-4
 
 
C
ry
st
al
lin
e 
si
ze
 (n
m
)
Concentration of CTAB (M)
 
Fig. 7 Crystallite size on (002) plane of the synthesized HA with various CTAB 
concentrations. ( , with CTAB; ▲, without CTAB) 
 
 16
3-2-2 溶劑 
圖9為添加1x10-3M CTAB於不同水-酒精濃度比之NaOH水溶液中，在75oC水解
合成1 h所獲得的HA粉末XRD繞射圖。由圖5的結果知在未加入酒精時，於(002)
之繞射面有最小的晶粒尺寸，在(002)亦有相對其他XRD圖寬化的狀況。但在加入
10%酒精後，(002)強度迅速增加而變得狹長，顯示在(002)繞射面之結晶性變化，
但繞射角的變化並不明顯。隨著酒精添加濃度的增加，除(002)之繞射強度逐漸
減少並發生寬化，並無其他雜相形成。 
    由於繞射峰之強度與半高寬的變化相當明顯，以(002)之布拉格角度及半高
寬以雪若方程式計算晶粒大小，其結果如圖10所示。較之未添加前之結果(由圖1
計算而得)發現，在未添加酒精時(0A-100W)，計算結果與圖7符合，從未添加CTAB
的計算結果中發現在(002)面的粒徑大小有略隨酒精濃度之增加而遞減的趨勢，
但比對圖1之XRD圖形，亦可發現在酒精濃度小於50%時，晶粒大小皆在22-24 nm
的範圍內，在酒精濃度高於50%時，晶粒大小則迅速下降，已與添加CTAB的最小
晶粒16-17 nm相當。而添加1x10-3 M CTAB後，在10%酒精濃度時的晶粒迅速增大
至21.5 nm，而後再隨酒精濃度之增加而遞減。在70%酒精濃度時皆有一往上提升
的反曲點，但此反曲點的變化幅度在添加1x10-3M CTAB時較小，此一現象將於稍
後再加以討論。 
    由圖3可知，HA無論在水中或酒精中皆呈現負表面電位，但HA在酒精中的極
性較在水中為高。HA之晶體結構屬於六方晶系，在c軸呈現正電性，而在a與b軸
則呈現負電性，因此在酒精-水的溶液中，其表面電荷性質會隨酒精濃度之變化
而改變。 
    圖1與圖9中於不同酒精濃度水解及CTAB之添加合成之HA在(002)面的繞射角
(2θ)如圖10所示，未添加CTAB時，繞射角度呈現隨酒精添加量之增加而遞增，
但添加1x10-3M CTAB後，則呈現先降後升的趨勢，變化幅度雖不大，但由於(002)
之繞射角的改變表示c軸向的變化，而此一變化亦表示晶格結構有所改變。 
較之圖5之結果，發現添加1x10-3 M CTAB與未添加時之主要差異在a軸之晶格
常數的下降，而c軸向的晶格常數則不變，此為CTAB與PO43-交互作用的結果如圖
11所示，未添加CTAB時，HA之(002)面的2θ角度隨酒精濃度的增加而提高，由布
拉格定律可知其晶格面的間距下降。但添加CTAB後則為先升後降，晶格結構的改
變來自於缺陷的產生，因此可判定酒精添加在晶格內部造成空缺的產生，致使晶
 18
由微小晶粒以及非晶HA所造成，並非所有的單顆析出物就是單一晶粒。在圖15(e)
的高解析TEM影像可觀察到一個具有明顯晶格排列的晶粒，此一晶粒中心較亮而
周圍較暗，表示為一中心凹陷的橢圓形晶粒，此凹陷孔洞的直徑約為5 nm。在含
酒精的系列的實驗中常可發現此現象，並可在其他TEM圖中發現這種不均勻的小
白點，表示為一經常存在之缺陷，可能因此造成晶格常數的下降。而在含90%酒
精濃度時，析出物聚集成一團，可觀察到更多非晶物的出現。 
圖16為未添加以及添加1x10-3 M CTAB後，於含不同酒精濃度之2.5 M NaOH(aq)
中所合成HA粉末之BET的量測結果，根據BET之結果換算所得之比表面積列於表1
中，在相對壓力(P/P0)約0.4~0.5開始有H4型遲滯現象，表示孔洞通常為盤狀或
者粒子相互連結所產生狹小的細縫型孔洞造成。在添加CTAB後，無酒精狀況下的
HA吸脫附曲線與未添加前類似，由表1中之結果可知其比表面積由109.23 m2/g增
加到125.31 m2/g。加入10%酒精之後，其比表面積僅增加1.47 m2/g，但是吸脫附
曲線之型態則有轉變的趨勢，而在添加50%的酒精時比表面積由126.78 m2/g增加
到149.22 m2/g，並且轉為H2型的遲滯現象，亦即表面型態轉變為具有細頸而寬
體(ink bottle)形狀之孔洞脣。酒精濃度繼續增加到90%時，比表面積下降至未
添加前之水準(102.82 m2/g)，由圖15(f)之結果可知此時主要形成非晶型HA晶粒
團聚，比表面積的數值下降。 
 
20 25 30 35 40 45 50 55
30
0
00
4
90A-10W
70A-30W
50A-50W
30A-70W
0A-100W
10A-90W
00
2
 
 
In
te
ns
ity
 (a
.u
.)
2θ
 
Fig. 9 The XRD patterns of HA synthesized as added with 1x10-3M CTAB in 2.5 M 
NaOH solution of various alcohol-water ratios at 75oC for 1 h. 
 
 20
 
0 20 40 60 80 100
30
35
40
45
50
55
60
65
70
75
80
 
 
I 00
2/I
21
1 (
%
)
Alcohol concentration (%)
 no CTAB
 1x10-4
 3x10-4
 1x10-3
 3x10-3
 1x10-2
 
Fig. 12 The I002/I211 of HA synthesized in 2.5 M NaOH solution of various 
alcohol-water ratio and various CTAB concentrations at 75oC for 1 h. 
 
 
 
 
0 20 40 60 80 100
-20
-10
0
10
20
30
40
50
 
 
Su
rf
ac
e 
po
te
nt
ia
l (
m
V)
Alcohol content (%)
 HA
 DCPD
 CTAB
 
Fig.13 The surface potential of HA and DCPD adding 1x10-3 M CTAB in solutions 
with various alcohol concentrations. 
 
 22
  
  
  
Fig. 15 The HR-TEM images of HA synthesized in 2.5 M NaOH solution at 75oC for 
1 h with various alcohol-water ratio：(a) no CTAB, and with 1x10-3M 
CTAB：(b) 0A-100W, (c) 10A-90W, (d)(e) 50A-50W, and (f) 90A-10W. 
 
50nm 
50nm 
50nm 50nm 
10nm 
50nm 
(a) 
(c) 
(b)
(d)
(e) (f)
 24
Table 1 The BET results of HA synthesized in 2.5 M NaOH solution with various 
alcohol-water ratios and different CTAB contents at 75oC for 1 h. 
Sample 
0A-100W 
No CTAB 
0A-100W 
1x10-3 M CTAB
10A-90W 
1x10-3 M CTAB
50A-50W 
1x10-3 M CTAB 
90A-10W 
1x10-3 M CTAB
Surface 
area 
(m2/g) 
109.23 125.31 126.78 149.22 102.82 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 26
參考文獻 
[1] L.L. Hench, J. Am. Ceram. Soc. 81 (1998) 1705. 
[2] R.H. Doremus, J. Mater. Sci. 27 (1992) 285. 
[3] J.M. Gomez-Vega, E. Saiz, A.P. Tomsia, G.W. Marshall, S.J. Marshall, 
Biomaterials 21 (2000) 105. 
[4] W.J. Shih, Y.F. Chen, M.C.Wang and M.H. Hon, J. Crystal Growth, 270(2004) 
211-218. 
[5] S. F. Hulbert, CRC Handbook of Bioactive Ceramics, edited by T. Yamamure, L. 
L. Hench, and J. Wilson, CRC Press Inc., Boca Raton, Florida, 1990, Vol. I, 
pp.3-6. 
[6] 王寶琪, 國立成功大學材料所博士論文(1994) , pp.28-30. 
[7] F.C.M. Driessens, Bioceramic of Calcium Phosphate, Edited by K. de Groot, CRC 
Press Inc., Boca Raton, Florida, 1983, p.1-32. 
[8] H. Tagai and H. Aoki, Mechanical Properties of Biomaterials, Edited by G.W. 
Hastins and J. Upton, John Wiley ＆ Sons Press, 1980, p.477. 
[9] K. Ohta, M. Kikuchi, J. Tanaka, and H. Eda, Chem. Lett. 2002, 894-895. 
[10] M. Jarcho, C.H. Bolen, M.B. Thomas, J. Bobick, J.F. Kay, and R.H. Doremus, J. 
Mater. Sci., 11 (1976) 2027. 
[11] J. Zhou, X. Zhang, J. Chen, S. Zeng, and K. de Groot, J. Mater. Sci. : Mater. 
Med., 4 (1993) 83. 
[12] TheWorld's No.1 Science & Technology News Service, Nanotechnology may 
create new organs, NewScientist.com news service, 8 July 2003. 
[13] K. Ishikawa, P. Ducheyne, S. Radin, J. Mater. Sci.: Mater. Med., 4(2), (1993) 
165-168. 
[14] L. Yubao, J.de Wijn, C.PA.T. Klein, S. van DeMeer, Kde Groot, J. Mater. Sci.: 
Mater. Med., 5(5),(1994) 252-255. 
 1
Synthesis nanosized of nearly spherical hydroxyapatite bioceramic 
powders using a hydrolysis process 
Moo-Chin Wanga,*,Wei-Jen Shihb, Kuo-Ming Changc, I-Ming Hungd, Huey-Er Leee, 
Min-Hsiung Honf, Wang-Long Lig 
 
a Department of Fragrance and Cosmetic Science, Kaohsiung Medical University, 
100 Shih-Chuan 1st Road, Kaohsiung 807, Taiwan 
b Metal Industries Research and Development Centre, 1001 Kaonan Highway, 
Kaohsiung 81160, Taiwan 
c Department of Mechanical Engineering, National Kaohsiung University of Applied 
Sciences, 415 Chien-Kung Road, Kaohsiung 80782, Taiwan 
d Department of Chemical Engineering and Materials Science, Yuan Ze University, 135 
Yuan-Tung Road, Chungli, Taoyunn 320, Taiwan 
e School of Dentistry, Kaohsiung Medical University, 100 Shih-Chuan 1st Road, 
Kaohsiung 807, Taiwan 
f Department of Materials Science and Engineering, National Cheng Kung 
University, 1 Ta-Hsueh Road, Tainan 70101, Taiwan 
g Institute of Nanotechnology and Microsystems Engineering, National Cheng Kung 
University, 1 Ta-Huseh Road, Tainan 70101, Taiwan 
 
 
 
 
 
 
*corresponding author : e-mail address : mcwang@kmu.edu.tw   
Tel: (07) 3121101 ext. 2366 
Fax: (07) 3210683 
 3
I.  Introduction 
Hydroxyapatite (HA) and other related calcium phosphate minerals are mainly used 
in the field of bioceramics, such as for artificial bones and teeth, due to their identical 
chemical composition and high biocompatibility with natural bones, and hence have 
received considerable attention over the past two decades as implant materials.1,2 HA 
is also frequently used as a drug carrier, ocular implant, scaffold matrix for tissue 
engineering, and as a coating agent on biomedical implants.3,4 However, applications 
of HA are currently limited to powders, coatings, porous bodies, and nonload-bearing 
implants due to processing difficulties and the poor mechanical properties of 
conventional HA.5 
Microscale HA is typically a highly stable phase (i.e. less bioresorbable), which is 
an undesirable characteristic because it impedes the rate of bone regeneration when 
used as a bone substitute in alveolar ridge augmentation related orthopedic surgery.6 
The resorbability of HA can be improved with the help of some ceramic oxides and 
ionic doping agents7,8 or by reducing its grain size to the nano-level.9 In fact, natural 
bone is a nanocomposite formed by mineral and organic fractions, which together 
confer mechanical resistance.4 In order to simulate the natured structure, the synthesis 
of nanosized HA has received a lot of attention in recent years.5 
Engineering HA at the nano-level would give it amazing functional properties due 
to its grain size, large surface area to volume ratio, and ultra fine structure similar to 
biological apatite, which would have a great impact on the implant-cell interaction in 
a body environment. Further, osteoconductivity, solubility, sinterability, and 
mechanical reliability of HA can be promoted by controlling its particle size and 
structural morphology on the nanoscale.10,11 Moreover, Webster et al.12 compared the 
conventional HA (17 nm grain size) and found that formation of resorption pits was 
 5
II.  Experimental procedure 
(1)  Sample preparation  
The ratios of added alcohol concentrations range from 0 to 100%. After mixing 
the aqueous solutions with various ratios of alcohol, the 2.5 M NaOH (purity 95%, 
supplied by Nihon Shiyaku reagent, Japan) solutions for hydrolysis was prepared by 
these mixtures. Firstly, 100 ml of NaOH solution with various alcohol (purity 99.5%, 
supplied by J. T. Baker Solusorb, Malaysia) concentrations was heated to 75oC, then 
an 1 x 10-3 M CTAB (purity 96.6%, supplied by Fluka, USA) was added to the 
solution until it was totally dissolved. Subsequently, 0.1 M calcium hydrogen 
phosphate dihydrate (CaHPO4•2H2O, DCPD), (purity 98%, supplied by Riedel-de 
Haën, Germany) was then added to the solution and mixed at 75oC for 1 h. After the 
solution became homogeneous, it was cooled in ice water. The precipitates were 
filtered and rinsed in deionized water five times. Finally, the powders were dried at 
60 oC in air. 
 (2)  Sample characterization 
The samples of HA and DCPD for zeta potential measurement were prepared by 
mixing 0.1g powders respectively, in 100 ml solutions of alcohol concentrations 
from 0 to 90 % with or without CTAB addition, ultrasonic dispersed for 15 min, 
agitated for 5 min, and ultrasonic dispersed again for another 15 min. The samples 
of 1 x 10-3 M CTAB for zeta potentials were prepared in the similar way. Since it 
was also the critical micelle concentration (CMC)19 of CTAB, the zeta potentials of 
CTAB micelle were obtained here. 
The crystalline phases and lattice parameters of the heated samples, with Si 
powders as a standard for calibration, were examined using X-ray diffractrometer 
(XRD, Rigaku D-Max/IIIV, Tokyo, Japan), with monochromatic CuKα radiation 
 7
alcohol concentration increasing from 0 to 70%, then slightly increases from 97.087 
to 105.485 when alcohol concentration increases from 70 to 90%. Moreover, the 
values of 1 / cosθ near maintain at 1.026 with alcohol concentration increasing from 
0 to 70%, then decrease from 1.026 to 1.0 when alcohol concentration increases 
from 70 to 90%. This result of 1 / βcosθ creates the HA nanopowders to have a 
minimum size for the alcohol concentration at 70%. The diffraction peaks of (002) 
and (004) are broadened and the crystals are less elongated in the c-axis direction of 
the hexagonal structure of HA.21 The results of Figs.1 indicates that the potential 
change does not cause minor phase are not forming because the phase transition 
with the specific crystallized orientation in the c-axis of HA is avoided. 
The intensity of the (002) reflection of HA can be used to identify the change in 
the c-axis of HA hexagonal structure. The intensity of (002) (denoted by I002) is 40% 
of the strongest intensity of (211) (denoted by I211). Fig.2 illustrates the effect of 
alcohol addition on the crystallinity of HA powders obtained using DCPD 
hydrolysis with 1x10-3 M CTAB at 75oC for 1h. When no alcohol is added, I002 is 
about 66.34% of I211, according to the specific crystallized orientation in the c-axis 
of HA in the hydrolysis process.22 When 10% alcohol is added, I002 slightly increases 
to 74.65% of I211, which reveals that an alcohol concentration of 10% affects the 
crystallization of HA. Subsequently, the ratio of I002/I211 abruptly decreases from 
74.65 to 45.38% when the alcohol concentration increases from 10 to 70%. The ratio 
of I002/I211 increases from 45.38 to 52.96% when the concentration increases from 70 
to 90%. Compared to the results of Shih et al.,19 the alcohol addition has an 
inhibiting effect on the crystallization of HA nanopowders. 
By the Scherrer’s equation:23 
Dhkl = 0.89λ / βcosθ                         (1) 
 9
with a diameter of about 10.0 nm, as shown in Fig.4d. The morphology of HA 
powders synthesized with 90% alcohol is shown in Fig.4e. It reveals that the 
morphology transforms from a nearly spherical shape to a rod shape with 30.0 nm in 
length and 25.0 nm in width. 
Generally, the overall electrophoretic mobility ( or zeta-potential ) may be 
considered to be related to the crystal morphology and also the relative 
predominance surface area of particular orientation of crystal face; and understanbly, 
the siginificance of a nearly spherical crystallite product of HA can reduce the 
orientayion effect on the electrophoretic mobility as well as the surface changes on 
the particle. This above consideration may be noted to represent the major 
contribution of this syudy.24 
  From this result and that of Figs. 3 and 4, it can be noted that the crystallite size is 
about 17.6 nm when alcohol concentration is at 50 %, but the morphology of HA has 
an acicular shape. Moreover, when the alcohol concentration is 90 %, the crystallite 
size of HA is 14.9 nm, but the morphology of HA also shows a rod shape. 
Furthermore, when the alcohol concentration is 70 %, the crystallite size of HA is 
13.7 nm and the morphology has a nearly spherical shape. These results indicate that 
no malter the alcohol concentration greater or smaller than 70 %, and crystallite size 
still has a nanometer scale, the morphology of HA does not present a nearly 
spherical shape.  
A TEM micrograph of HA powders with 1x10-3 M CTAB and 0% alcohol solution 
synthesized at 75oC for 1h is shown in Fig.5a. The crystal shape of HA has a rod 
shape with a length and width of 30.0 and 15.0 nm, respectively. When the 
concentration of added alcohol increases from 0 to 50%, the morphology still has a 
short rod shape, but the length and width decrease from 30.0 to 15.0, and 15.0 to 
 11
shows a nearly spherical shape with a diameter of about 10.0 nm. Moreover, for a 
solution containing alcohol concentrations of 10, 50, and 90%, the SEM morphology 
of the HA nanopowders has a rod shape and the particle size decreases with alcohol 
content. Thus, it appears that the addition of 70% alcohol, represent the critical 
concentration of alcohol addition for the optimum growth a nearly spherical shape of 
HA crystallites. 
 
Acknowledgement 
The authors gratefully acknowledge the financial support by the National Science 
Council (NSC95-2221-E-037-007), Mr. H.Y. Yao for TEM/EDS experimentation, 
Mr. F.C. Wu for SEM photography, and Prof. M. P. Hung for his suggestion during 
the manuscript preparation. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 13
References 
(1) Jarcho, M.; Bolen, C.H.; Thomas, M.B.; Bobick, J.; Kay, F.; Dorcmus, R.H. J. 
Mater. Sci. 1976, 11, 2027. 
(2) Akoi, H.; Kato, K.; Ogiso, M.; Tabata, T., J. Dental. Outlook. 1977, 49, 567. 
(3) Currey, J., Nature, 2001, 414, 699. 
(4) Lim, G.K.; Wang, J.; Ng, S.C.; Gan, L.M. Mater. Lett. 1996, 28[4-6], 431. 
(5) Suchanek, W.; Yoshimura, M. J. Mater. Res. 1998, 13, 94. 
(6) Kivrak, N.; Tas, A.C. J. Am. Ceram. Soc. 1998, 81[9], 2245. 
(7) Murugan, R., Kumar, T.S.S.; Rao, K.P.; Mater. Lett. 2002, 57, 429. 
(8) Murugan, R; Ramakrishna, S. Mater. Lett. 2003, 58, 230. 
(9) Driessens, F.C.M.; Boltong, M.G.; Maeyer, E.A.P.; Wenz, D. R.; Nies, R.; 
Planell, J.A. Biomaterials 2002, 23, 4011. 
(10) LeGeros, R.Z. Karger. Basel. Switzerland 1991, 15, 151. 
(11) Li, Y.; Wijn, J.R.D.; Klein, C.P.A.T.; Meer, S.V.D.; Groot, K.D. J. Mater. Sci. 
Mater. Med. 1994, 5, 252.  
(12) Webster, T.J.; Ergun, C., Doremous, R.H.; Siegal, R.W.; Bizios, R. 
Biomaterials 2001, 22, 1327.  
(13) K. Ohta, M. Kikuchi, J. Tanaka, and H. Eda, “Synthesis of c axes oriented 
hydroxyapatite aggregate,” Chem. Lett. 9 894-5 (2002). 
(14) Yen, S.K.; Lin, C.M. Mater. Chem. Phys. 2003, 77, 70. 
(15) Ban, S.; Hasegawa, J. Biomaterials 2002, 23, 2965. 
(16) Hwang, K.; Lim, Y. Surf. Coat. Tech. 1999, 115, 172. 
(17) Haddow, D.B.; James, P.F.; Noort, R. Van. J. Mater. Sci. Mater. Med. 1996, 7, 
255.  
(18) Koumoulidis, G.C.; Katsoulidis, A.P.; Ladavos, A.K.; Pomonis, P.J.; Trapalis, 
 15
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
20 25 30 35 40 45 50 55
(1
12
)
(2
11
)
(3
00
)
(2
02
)
(1
12
)
In
te
ns
ity
 (a
.u
.)
2 θ
(2
02
)
(3
00
)
(0
04
)
(2
13
)
(2
22
)
(3
10
)
(0
02
)
(2
11
)
(f)
(e)
(d)
(c)
(b)
(a)
 
 
 
 
 
Fig.1 
 
 
 
 
 
 
 17
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
14
16
18
20
22
24
90705030100
Alcohol concentration (%)
C
ry
st
al
lit
e 
si
ze
 (n
m
)
 
 
 
Fig.3 
 
 
 
 
 
 
 
 
 19
 
 
   
 
   
 
 
 
 
 
 
Fig. 5 
(a) 
(c) 
20 nm
(b)
20 nm 
20 nm
(d)
20 nm 
20 nm
(e) 
